DAB389-CD4

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameDAB389-CD4
Drug Alias NameCD4 fusion toxin (Ligand)CD4 fusion toxin (Seragen)CD4 fusion toxin (Seragen/Ligand)DAB389-CD4
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Toxin
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasmsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSeragen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSeragen IncLigand Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasmsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A